Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1978 Sep-Oct;78(5):781-6.

[Indications for mianserin in relation to its absence of side-effects (author's transl)]

[Article in French]
  • PMID: 375682
Clinical Trial

[Indications for mianserin in relation to its absence of side-effects (author's transl)]

[Article in French]
M A Calanca. Acta Psychiatr Belg. 1978 Sep-Oct.

Abstract

About twenty-five years ago thymoleptics made their first appearance which were soon followed by a great number of pharmacological agents that allied a mood elevating activity to an anxiolytic effect. Mianserin, a novel tetracyclic antidepressant, has an antidepressive effect similar to that of its predecessors but without causing the following side-effects : dry mouth, constipation, intestinal atony, tachycardia, cardiac rhythm disorders, accommodation difficulties, intra-ocular hypertension, dizziness, bladder atony and urinary retention. Consquently, its use is particularly indicated for the treatment of those patients who did not react to other antidepressants of those who stopped treatment on account of side-effects. Mianserin may also be used with those patients suffering from glaucoma, urinary or prostatic disorders and cardiac disorders even when the patient is recovering from a recent heart infarction. Furthermore it is recommended for aged people, for patients in a bad general condition and for those who were in a confusioned state during treatment with tricyclic antidepressants.

PubMed Disclaimer

Similar articles

LinkOut - more resources